UniProt ID | DDX41_HUMAN | |
---|---|---|
UniProt AC | Q9UJV9 | |
Protein Name | Probable ATP-dependent RNA helicase DDX41 | |
Gene Name | DDX41 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 622 | |
Subcellular Localization | Nucleus . | |
Protein Description | Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing.. | |
Protein Sequence | MEESEPERKRARTDEVPAGGSRSEAEDEDDEDYVPYVPLRQRRQLLLQKLLQRRRKGAAEEEQQDSGSEPRGDEDDIPLGPQSNVSLLDQHQHLKEKAEARKESAKEKQLKEEEKILESVAEGRALMSVKEMAKGITYDDPIKTSWTPPRYVLSMSEERHERVRKKYHILVEGDGIPPPIKSFKEMKFPAAILRGLKKKGIHHPTPIQIQGIPTILSGRDMIGIAFTGSGKTLVFTLPVIMFCLEQEKRLPFSKREGPYGLIICPSRELARQTHGILEYYCRLLQEDSSPLLRCALCIGGMSVKEQMETIRHGVHMMVATPGRLMDLLQKKMVSLDICRYLALDEADRMIDMGFEGDIRTIFSYFKGQRQTLLFSATMPKKIQNFAKSALVKPVTINVGRAGAASLDVIQEVEYVKEEAKMVYLLECLQKTPPPVLIFAEKKADVDAIHEYLLLKGVEAVAIHGGKDQEERTKAIEAFREGKKDVLVATDVASKGLDFPAIQHVINYDMPEEIENYVHRIGRTGRSGNTGIATTFINKACDESVLMDLKALLLEAKQKVPPVLQVLHCGDESMLDIGGERGCAFCGGLGHRITDCPKLEAMQTKQVSNIGRKDYLAHSSMDF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MEESEPERKRA ----CCCCHHHHHHC | 45.18 | 29255136 | |
9 | Sumoylation | EESEPERKRARTDEV CCCHHHHHHCCCCCC | 49.07 | - | |
9 | Sumoylation | EESEPERKRARTDEV CCCHHHHHHCCCCCC | 49.07 | - | |
13 | Phosphorylation | PERKRARTDEVPAGG HHHHHCCCCCCCCCC | 35.21 | 23927012 | |
21 | Phosphorylation | DEVPAGGSRSEAEDE CCCCCCCCCCCCCCC | 31.54 | 29255136 | |
23 | Phosphorylation | VPAGGSRSEAEDEDD CCCCCCCCCCCCCCC | 42.74 | 19664994 | |
33 | Phosphorylation | EDEDDEDYVPYVPLR CCCCCCCCCCCCCHH | 10.98 | 23927012 | |
36 | Phosphorylation | DDEDYVPYVPLRQRR CCCCCCCCCCHHHHH | 12.49 | 23927012 | |
49 | Ubiquitination | RRQLLLQKLLQRRRK HHHHHHHHHHHHHHC | 51.65 | 21890473 | |
56 | Acetylation | KLLQRRRKGAAEEEQ HHHHHHHCCHHHHHH | 51.60 | 26051181 | |
66 | Phosphorylation | AEEEQQDSGSEPRGD HHHHHHCCCCCCCCC | 39.62 | 29255136 | |
68 | Phosphorylation | EEQQDSGSEPRGDED HHHHCCCCCCCCCCC | 48.67 | 29255136 | |
71 | Methylation | QDSGSEPRGDEDDIP HCCCCCCCCCCCCCC | 62.23 | - | |
83 | Phosphorylation | DIPLGPQSNVSLLDQ CCCCCCCCCCHHHHH | 42.19 | 23927012 | |
86 | Phosphorylation | LGPQSNVSLLDQHQH CCCCCCCHHHHHHHH | 27.71 | 23403867 | |
95 | Ubiquitination | LDQHQHLKEKAEARK HHHHHHHHHHHHHHH | 55.85 | - | |
111 | Sumoylation | SAKEKQLKEEEKILE HHHHHHHHHHHHHHH | 61.66 | - | |
111 | Sumoylation | SAKEKQLKEEEKILE HHHHHHHHHHHHHHH | 61.66 | - | |
115 | Ubiquitination | KQLKEEEKILESVAE HHHHHHHHHHHHHHH | 56.74 | - | |
128 | Phosphorylation | AEGRALMSVKEMAKG HHHHHHHCHHHHHCC | 30.78 | 24719451 | |
130 | Acetylation | GRALMSVKEMAKGIT HHHHHCHHHHHCCCC | 34.17 | 25953088 | |
130 | Ubiquitination | GRALMSVKEMAKGIT HHHHHCHHHHHCCCC | 34.17 | - | |
138 | Phosphorylation | EMAKGITYDDPIKTS HHHCCCCCCCCCCCC | 19.21 | - | |
143 | Ubiquitination | ITYDDPIKTSWTPPR CCCCCCCCCCCCCCC | 41.72 | - | |
145 | Phosphorylation | YDDPIKTSWTPPRYV CCCCCCCCCCCCCEE | 24.77 | 30631047 | |
147 | Phosphorylation | DPIKTSWTPPRYVLS CCCCCCCCCCCEEEC | 24.15 | 21815630 | |
154 | Phosphorylation | TPPRYVLSMSEERHE CCCCEEECCCHHHHH | 15.37 | 30631047 | |
156 | Phosphorylation | PRYVLSMSEERHERV CCEEECCCHHHHHHH | 32.69 | 20860994 | |
182 | Phosphorylation | GIPPPIKSFKEMKFP CCCCCCCCHHHCCCH | 42.12 | 24719451 | |
194 | Methylation | KFPAAILRGLKKKGI CCHHHHHHHHHHCCC | 42.14 | - | |
199 | Ubiquitination | ILRGLKKKGIHHPTP HHHHHHHCCCCCCCC | 62.60 | - | |
232 | Phosphorylation | AFTGSGKTLVFTLPV EECCCCCEEEEEHHH | 31.51 | 24114839 | |
236 | Phosphorylation | SGKTLVFTLPVIMFC CCCEEEEEHHHHHHH | 23.75 | 24114839 | |
254 | Ubiquitination | EKRLPFSKREGPYGL HCCCCCCCCCCCCEE | 55.64 | - | |
259 | Phosphorylation | FSKREGPYGLIICPS CCCCCCCCEEEECCC | 35.11 | 28152594 | |
288 | Phosphorylation | CRLLQEDSSPLLRCA HHHHHCCCCHHHHHH | 32.86 | 27966365 | |
289 | Phosphorylation | RLLQEDSSPLLRCAL HHHHCCCCHHHHHHH | 31.71 | 26699800 | |
302 | Phosphorylation | ALCIGGMSVKEQMET HHHHCCCCHHHHHHH | 33.06 | 24719451 | |
320 | Phosphorylation | GVHMMVATPGRLMDL CCCEEECCHHHHHHH | 18.18 | 23312004 | |
330 | Ubiquitination | RLMDLLQKKMVSLDI HHHHHHHHHCCCHHH | 42.69 | - | |
330 | Acetylation | RLMDLLQKKMVSLDI HHHHHHHHHCCCHHH | 42.69 | 25953088 | |
331 | Ubiquitination | LMDLLQKKMVSLDIC HHHHHHHHCCCHHHH | 31.41 | - | |
331 | Acetylation | LMDLLQKKMVSLDIC HHHHHHHHCCCHHHH | 31.41 | 27452117 | |
364 | Phosphorylation | DIRTIFSYFKGQRQT CHHHHHHHHCCCCEE | 9.88 | - | |
366 | Methylation | RTIFSYFKGQRQTLL HHHHHHHCCCCEEEE | 45.99 | - | |
381 | Ubiquitination | FSATMPKKIQNFAKS EECCCCHHHHHHHHH | 43.59 | - | |
388 | Phosphorylation | KIQNFAKSALVKPVT HHHHHHHHHCCCCEE | 24.33 | 20860994 | |
392 | Sumoylation | FAKSALVKPVTINVG HHHHHCCCCEEEECC | 34.32 | - | |
392 | Sumoylation | FAKSALVKPVTINVG HHHHHCCCCEEEECC | 34.32 | - | |
392 | Ubiquitination | FAKSALVKPVTINVG HHHHHCCCCEEEECC | 34.32 | - | |
395 | Phosphorylation | SALVKPVTINVGRAG HHCCCCEEEECCCCC | 18.50 | - | |
405 | Phosphorylation | VGRAGAASLDVIQEV CCCCCCCCCHHHHHH | 25.27 | 28348404 | |
414 | Phosphorylation | DVIQEVEYVKEEAKM HHHHHHHHHHHHHHH | 23.23 | - | |
416 | Ubiquitination | IQEVEYVKEEAKMVY HHHHHHHHHHHHHHH | 49.27 | - | |
416 | Sumoylation | IQEVEYVKEEAKMVY HHHHHHHHHHHHHHH | 49.27 | - | |
416 | Sumoylation | IQEVEYVKEEAKMVY HHHHHHHHHHHHHHH | 49.27 | 28112733 | |
416 | Acetylation | IQEVEYVKEEAKMVY HHHHHHHHHHHHHHH | 49.27 | 25953088 | |
441 | 2-Hydroxyisobutyrylation | PVLIFAEKKADVDAI CEEEEECCCCCHHHH | 50.24 | - | |
442 | Ubiquitination | VLIFAEKKADVDAIH EEEEECCCCCHHHHH | 41.13 | - | |
442 | Sumoylation | VLIFAEKKADVDAIH EEEEECCCCCHHHHH | 41.13 | - | |
442 | Sumoylation | VLIFAEKKADVDAIH EEEEECCCCCHHHHH | 41.13 | 28112733 | |
455 | Ubiquitination | IHEYLLLKGVEAVAI HHHHHHHHCCEEEEE | 61.96 | - | |
466 | Ubiquitination | AVAIHGGKDQEERTK EEEECCCCCHHHHHH | 61.91 | - | |
473 | Ubiquitination | KDQEERTKAIEAFRE CCHHHHHHHHHHHHH | 54.29 | - | |
482 | Ubiquitination | IEAFREGKKDVLVAT HHHHHHCCCCEEEEE | 40.84 | - | |
493 | Phosphorylation | LVATDVASKGLDFPA EEEEHHHCCCCCCCH | 27.40 | 24114839 | |
523 | Phosphorylation | YVHRIGRTGRSGNTG HHHHHCCCCCCCCCC | 31.56 | 20068231 | |
526 | Phosphorylation | RIGRTGRSGNTGIAT HHCCCCCCCCCCEEH | 37.43 | 20068231 | |
529 | Phosphorylation | RTGRSGNTGIATTFI CCCCCCCCCEEHHHH | 33.23 | 28509920 | |
533 | Phosphorylation | SGNTGIATTFINKAC CCCCCEEHHHHHHHC | 21.96 | 20068231 | |
534 | Phosphorylation | GNTGIATTFINKACD CCCCEEHHHHHHHCC | 17.31 | 28509920 | |
538 | Ubiquitination | IATTFINKACDESVL EEHHHHHHHCCHHHH | 45.64 | - | |
549 | Ubiquitination | ESVLMDLKALLLEAK HHHHHHHHHHHHHHH | 32.49 | - | |
556 | Ubiquitination | KALLLEAKQKVPPVL HHHHHHHHHHCCCEE | 41.08 | - | |
572 | Phosphorylation | VLHCGDESMLDIGGE EEEECCHHHCCCCCC | 29.41 | 30576142 | |
597 | Ubiquitination | HRITDCPKLEAMQTK CCCCCCHHHHHHHCC | 66.35 | - | |
603 | Phosphorylation | PKLEAMQTKQVSNIG HHHHHHHCCCCCCCC | 15.45 | 22673903 | |
604 | Ubiquitination | KLEAMQTKQVSNIGR HHHHHHCCCCCCCCC | 31.63 | - | |
612 | Ubiquitination | QVSNIGRKDYLAHSS CCCCCCCCHHHHHCC | 45.58 | - | |
614 | Phosphorylation | SNIGRKDYLAHSSMD CCCCCCHHHHHCCCC | 14.60 | 26270265 | |
618 | Phosphorylation | RKDYLAHSSMDF--- CCHHHHHCCCCC--- | 23.04 | 25159151 | |
619 | Phosphorylation | KDYLAHSSMDF---- CHHHHHCCCCC---- | 16.71 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
414 | Y | Phosphorylation | Kinase | BTK | Q06187 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX41_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX41_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NKAP_HUMAN | NKAP | physical | 22365833 | |
CEP70_HUMAN | CEP70 | physical | 25416956 | |
CLVS2_HUMAN | CLVS2 | physical | 26344197 | |
PREP_HUMAN | PITRM1 | physical | 26344197 | |
ANR50_HUMAN | ANKRD50 | physical | 28514442 | |
CSK21_HUMAN | CSNK2A1 | physical | 28514442 | |
CAPON_HUMAN | NOS1AP | physical | 28514442 | |
PININ_HUMAN | PNN | physical | 28514442 | |
SIN3A_HUMAN | SIN3A | physical | 28514442 | |
SRRM2_HUMAN | SRRM2 | physical | 28514442 | |
RNPS1_HUMAN | RNPS1 | physical | 28514442 | |
BRM1L_HUMAN | BRMS1L | physical | 28514442 | |
CBY1_HUMAN | CBY1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY. |